AIRLINK 74.28 Decreased By ▼ -0.28 (-0.38%)
BOP 5.07 Increased By ▲ 0.01 (0.2%)
CNERGY 4.47 Increased By ▲ 0.01 (0.22%)
DFML 40.02 Increased By ▲ 0.29 (0.73%)
DGKC 86.96 Decreased By ▼ -0.59 (-0.67%)
FCCL 21.82 Decreased By ▼ -0.11 (-0.5%)
FFBL 35.05 Increased By ▲ 0.46 (1.33%)
FFL 9.95 Increased By ▲ 0.20 (2.05%)
GGL 10.58 Increased By ▲ 0.09 (0.86%)
HBL 114.06 Increased By ▲ 0.27 (0.24%)
HUBC 136.15 Decreased By ▼ -0.37 (-0.27%)
HUMNL 11.90 Increased By ▲ 1.00 (9.17%)
KEL 4.80 Increased By ▲ 0.13 (2.78%)
KOSM 4.67 Increased By ▲ 0.03 (0.65%)
MLCF 38.25 Decreased By ▼ -0.21 (-0.55%)
OGDC 136.01 Decreased By ▼ -0.13 (-0.1%)
PAEL 26.80 Increased By ▲ 0.19 (0.71%)
PIAA 20.80 Decreased By ▼ -1.69 (-7.51%)
PIBTL 6.75 Increased By ▲ 0.08 (1.2%)
PPL 122.65 Increased By ▲ 0.36 (0.29%)
PRL 27.04 Increased By ▲ 0.07 (0.26%)
PTC 14.48 Increased By ▲ 0.57 (4.1%)
SEARL 60.30 Increased By ▲ 0.43 (0.72%)
SNGP 70.30 Increased By ▲ 0.24 (0.34%)
SSGC 10.40 Increased By ▲ 0.05 (0.48%)
TELE 8.65 Increased By ▲ 0.11 (1.29%)
TPLP 11.27 Decreased By ▼ -0.07 (-0.62%)
TRG 65.25 Decreased By ▼ -0.75 (-1.14%)
UNITY 26.30 Decreased By ▼ -0.03 (-0.11%)
WTL 1.36 Increased By ▲ 0.01 (0.74%)
BR100 7,857 Increased By 32.8 (0.42%)
BR30 25,452 Increased By 46.1 (0.18%)
KSE100 75,323 Increased By 238.9 (0.32%)
KSE30 24,164 Increased By 70.1 (0.29%)
Markets

Tech shares lead Wall Street higher as potential vaccines show promise

  • Nasdaq on track for record closing high.
  • Chevron slips after agreeing to buy Noble Energy for $5 bln.
  • Halliburton rises after quarterly results.
  • Moderna sinks on competitors' vaccine trial results.
  • Indexes up: Dow 0.14%, S&P 0.61%, Nasdaq 1.81%.
Published July 21, 2020

NEW YORK: Wall Street advanced with the Nasdaq set to reach a record closing high on Monday, as investors pivoted away from cyclical stocks in favor of market leaders while new cases of COVID-19 spiraled but there were glimmers of hope that an effective vaccine will emerge.

Tech shares provided the biggest boost to all three major US stock indexes, but industrials were down, capping the Dow's gains.

Deaths in the United States from COVID-19 passed the 140,000 mark over the weekend, as cases continued to rise in 42 of 50 states.

Trials of potential vaccines have shown promise. Most recently, drugs from AstraZenica, CanSino Biologics Inc and from a partnership between Pfizer Inc and German biotech firm BioNTech were safely administered and induced immune responses.

"While there's good news on the vaccine front in early trials, the reality is setting in that it's going to take quite some time," Oliver Pursche, president of Bronson Meadows Capital Management in Fairfield Connecticut. "With industrials and materials down, that is not a reflection of a rebound in the economy."

The US Congress, still looking to mitigate the pandemic's economic effects, was set for a week of partisan wrangling over a new relief package, with two weeks until enhanced jobless benefits expire for millions of Americans.

The Dow Jones Industrial Average rose 37.52 points, or 0.14%, to 26,709.47, the S&P 500 gained 19.72 points, or 0.61%, to 3,244.45 and the Nasdaq Composite added 190.46 points, or 1.81%, to 10,693.65.

Of the 11 major sectors in the S&P 500, consumer discretionary and tech enjoyed the largest percentage gains.

Second-quarter earnings season chugged along. Some 48 companies in the S&P 500 have posted results, with 77.1% of those beating consensus, according to Refinitiv data.

In aggregate, analysts now expect S&P 500 second-quarter earnings to have dropped 43.2% year-on-year, per Refinitiv.

This week, Microsoft Corp, Amazon.com Inc, Tesla Inc and Intel Corp are among the high-profile companies expected to report quarterly results.

Shares Halliburton Co rose 3.5% after posting a surprise adjusted quarterly profit and better-than-expected cash flow due to cost-cutting.

Noble Energy Inc advanced 5.4% on news that Chevron Corp agreed to buy the oil and gas producer for $5 billion.

Chevron dropped 2.1%.

Moderna Inc dropped 15.1% on positive results from its competitors' rival COVID-19 drug trials.

After the bell, International Business Machines Corp is expected to post second-quarter results.

Declining issues outnumbered advancing ones on the NYSE by a 1.09-to-1 ratio; on Nasdaq, a 1.03-to-1 ratio favored advancers.

The S&P 500 posted 38 new 52-week highs and no new lows; the Nasdaq Composite recorded 111 new highs and 10 new lows.

Comments

Comments are closed.